Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1252-1261

  Sharif, N A ^a   Xu, S X ^a   Miller, S T ^a   Gamache, D A ^a   Yanni, J M ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; OLOPATADINE;

ALLERGIC CONJUNCTIVITIS; ALLERGY; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; EYE DISEASE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HYPERSENSITIVITY; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL;

ANTI-ALLERGIC AGENTS; BINDING, COMPETITIVE; CHYMASES; CONJUNCTIVA; DIBENZOXEPINS; EYE DISEASES; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMANS; KETOTIFEN; MAST CELLS; PHOSPHATIDYLINOSITOLS; PROSTAGLANDIN D2; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0030427026     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ABELSON, M. B. AND SCHAEFER, K.: Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy. Surv. Ophthalmol. 38: 115-132, 1993.
2. 2 receptors in the human ocular surface. Arch. Ophthalmol. 99: 302-304, 1981.
3. ALLANSMITH, M. R. AND ROSS, R. N.: Ocular allergy. Clin, Allergy 18: 1-13, 1988.
4. BEFUS, A. D., DYCK, N., GOODACRE, R. AND BIENENSTOCK, J.: Mast cells from the human intestinal lamina propria: Isolation, histochemical subtypes, and functional characterization. J. Immunol. 188: 2604-2610, 1987.
5. BERDY, G., ABELSON, M. B., GEORGE, M. A., SMITH, L. M. AND GIOVANONI, R. L.: Allergic conjunctivitis: A survey of new anti-histamines. J. Ocular Pharmacol. 7: 313-324, 1991.
6. BERRIDGE, M. J., DOWNES, C. P. AND HANLEY, M. R.: Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary gland. Biochem. J. 206: 587-595, 1982.
7. BEAVAN, M. A.: Factors regulating availability of histamine at tissue receptors. In Pharmacology of Histamine Receptors, ed. by C. R. Ganellin and M. E. Parsons, pp. 103-145, Wright, Bristol, England, 1982.
8. BOKESOY, T. A. AND ONARAN, H. O.: Atypical Schild plots with histamine H1 receptor agonists and antagonists in the rabbit aorta. Eur. J. Pharmacol. 197: 49-56, 1991.
9. BROWN, E., KENDALL, D. A. AND NAHORSKI, S. R.: Inpsitol phospholipid hydrolysis in rat cerebral cortex slices: Receptor characterization. J. Neurochem. 42: 1379-1387, 1984.
10. 3H]mepyramine binding of brain membranes. J. Neurochem. 32: 1653-1663, 1979.
11. DECHANT, K. L. AND GOA, K. L.: Levocabastine: A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 41: 202-224, 1991.
12. FURCHGOTT, R. F.: The classification of adrenoceptors (adrenergic receptors): An evaluation from the standpoint of receptor theory. In Handbook of Experimental Pharmacology, ed. by O. Eichler, A. Farah, H. Herken and A. D. Welch, vol. 33, pp. 283-335, Springer-Verlag, New York, 1972.
13. 2 receptors in guinea pig cerebral cortex. Nature (Lond.) 304: 65-67, 1983.
14. HILL, S. J.: Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42: 45-83, 1990.
15. 1 receptors in intestinal smooth muscle. Nature (Lond.) 270: 361-363, 1977.
16. 3H-histamine by glial cells in primary culture of chick cerebral hemispheres. Glia 3: 159-168, 1990.
17. TC in vernal conjunctivitis and giant papillary conjunctivitis. J. Allergy Clin. Immunol. 86: 34-39, 1990.
18. IRANI, A. AND SCHWARTZ, L.: Mast cell heterogeneity. Clin. Exp. Allergy 19: 143-155, 1989.
19. ISHII, H., KITAMURA, S. AND OHMORI, K: Inhibitory effect of KW-4679 on allergic models in rats. Jpn. J. Pharmacol. 55: suppl. 1, 375, 1991.
20. KATZ, H., STEVENS, R. AND AUSTEN, K.: Heterogeneity of mammalian mast cells differentiated in vivo and in vitro. J. Allergy Clin. Immunol. 76: 250-259, 1985.
21. 3 histamine receptors in guinea pigs by N-methylhistamine. Biochem. Biophys. Res. Commun. 168: 979-986, 1990.
22. LI, Q., WHITCUP, S. M., FUJINO, Y., NUSSENBLATT, R. B. AND CHAN, C.-C.: The role of mast cells in endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 34: 256-259, 1993.
23. MICHEL, A. D. AND WHITING, R. L.: Analysis of ligand binding data using a microcomputer. Br. J. Pharmacol. 83: 460P, 1984.
24. MILLER, S., COOK, E., GRAZIANO, F., SPELLMAN, J. AND YANNI, J.: Human conjunctival mast cell responses in vitro to various secretagogues. Ocular Immunol. Inflammation 4: 39-49, 1996.
25. 1 receptor. Jpn. J. Pharmacol. 61: suppl. 1, 87P, 1993.
26. OHSHIMA, E., OTAKI, S., SATO, H., KUMAZAWA, T., OBASE, H., ISHII, A., ISHII, H., OHMORI, K. AND HIRAYAMA, N.: Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihyrodiben[b,e]oxepin derivatives. J. Med. Chem. 35: 2074-2084, 1992.
27. PANG, I.-H., SHADE, D. L., CLARK, A. F., STEELY, H. T. AND DESANTIS, L. M.: Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr. Eye Res. 13: 51-63, 1994.
28. PROUD, D., SWEET, J., STEIN, P., SETTIPANE, R. A., KAGEY-SOBOTKA, A., FREIDLAENDER, M. H. AND LICHTENSTEIN, L. M.: Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J. Allergy Clin. Immunol. 85: 896-905, 1990.
29. SCHWARTZ, J.-C., ARRANG, J. M., GARBARG, M., POLLARD, H. AND RUAT, M.: Histaminergic transmission in the mammalian brain. Physiol. Rev. 71: 1-51, 1992.
30. SCHWARTZ, L. B.: Mediators of human mast cells and human mast cell subsets. Ann. Allergy 58: 226-235, 1987.
31. SHARIF, N. A. AND WHITING, R. L.: Stimulation of inositol phosphate production in clonal HDSDM1C1 cells by endothelins and sarafotoxin. Biochem. Pharmacol. 40: 1928-1931, 1990.
32. 3H]GR65630 binding. Br. J. Pharmacol. 102: 919-925, 1991.
33. SHARIF, N. A., XU, S. X., MAGNINO, P. E. AND PANG, I.-H.: Human conjunctival epithelial cells express histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilization: Role in ocular allergic diseases. Exp. Eye Res., in press, 1996a.
34. 1-selective antagonist for ocular use: Receptor binding and second messenger studies. J. Ocular Pharmacol. 10: 653-664, 1994.
35. 1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis. J. Ocular Pharmacol. Ther., in press, 1996b.
36. SPITALNY, L. AND ABELSON, M.: Olopatadine ophthalmic solution decreases itching and redness associated with allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci. 37: suppl., S593, 1996.
37. WOODWARD, D. F., LEDGARD, S. E. AND NIEVES, A. L.: Conjunctival immediate hypersensitivity: Re-evaluation of histamine involvement in the vasopermeability response. Invest. Ophthalmol. Vis. Sci. 27: 57-63, 1986.
38. YANNI, J. M., STEPHENS, D. J., MILLER, S. T., WEIMER, L. K., GRAFF, G., PARNELL, D., LANG, L. S., SPELLMAN, J. M., BRADY, M. T. AND GAMACHE, D. A.: The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/anti-histaminic agent. J. Ocular Pharmacol. Ther., in press, 1996.
39. 1 antagonist for topical ocular use. J. Ocular Pharmacol. 10: 665-675, 1994.